In Texas and in many other states, the answer is still generally yes. Private employers continue to have broad discretion to maintain drug-free workplace policies, to conduct pre-employment testing, and to make hiring decisions based on those results, as long as they apply their policy consistently and in a non-discriminatory way. State-level guidance for employers still recognizes pre-employment, random, post-accident, and “for cause” testing as allowed practices, and there is no broad prohibition on marijuana screening in the hiring process. In practice, that means marijuana rescheduling has changed the legal conversation, but it has not erased an employer’s ability to reject applicants who test positive for THC under an established hiring policy.
It is also important to understand what actually changed at the federal level. The recent rescheduling actions have focused on specific categories of marijuana products—such as certain FDA-approved formulations and products used within state-regulated medical programs—rather than declaring all marijuana use acceptable for employment purposes. The broader question of how marijuana is classified under federal law is still moving through a formal review process. For employers, that distinction matters because workplace decisions are still shaped by the exact wording of company policy, the nature of the job, and how the product was used, rather than by headlines about rescheduling alone.
Texas employers also have to view the issue through the lens of state law. Texas has expanded its medical marijuana program, but those changes have not created broad employment protections for applicants or employees who test positive for THC. Many Texas-focused resources still note that employers may refuse employment or take action based on a positive marijuana result, even where the individual claims lawful medical use under state rules. For hiring teams, the central question is usually not whether cannabis policy is evolving in general, but whether the employer’s written standards still prohibit detectable THC for the position at issue.
This is especially true in safety-sensitive environments. Employers in transportation, manufacturing, warehousing, construction, healthcare, and similar sectors often maintain stricter testing standards because impairment concerns can have immediate consequences for co-workers, patients, customers, and the public. Regulatory bodies have not required employers to permit employees to work while under the influence of marijuana, and certain federally regulated roles still prohibit marijuana use regardless of state law trends. When a position involves driving, operating machinery, direct patient care, hazardous materials, or compliance obligations imposed by a customer or government contract, employers remain on solid ground when they enforce a THC-related hiring standard that is clearly stated in advance.
At the same time, the rescheduling debate is forcing HR teams to rethink how they test and how they explain their process. Policies drafted years ago for urine testing alone may no longer reflect operational realities, particularly when organizations want faster hiring decisions and a testing method that better aligns with recent use. That is one reason more employers are exploring oral fluid methods and related products such as saliva drug test kits, a saliva drug test kit 10 panel, or an oral swab drug screen test for selected workplace scenarios. Oral fluid testing has become more widely recognized in workplace drug testing programs, and many laboratories describe it as suitable for pre-employment, post-accident, and reasonable suspicion testing. Because oral fluid collection is directly observed and less vulnerable to adulteration or substitution, many employers see it as a practical option when integrity of collection is important.
The appeal of oral fluid testing also relates to timing. Employers in the THC discussion are increasingly focused on the difference between recent use and historical exposure. Oral fluid tends to reflect a shorter detection window than urine for many substances, often aligning more closely with the period when drug use is most relevant to on-the-job performance. That makes oral fluid testing especially attractive in reasonable suspicion or post-accident situations, where the goal is to understand whether there has been recent use that might relate to observed behavior or an incident. Products such as an instant saliva drug screen or a saliva drug screen kit with alcohol are built around this need for quick, on-site screening that can identify a range of potential substances, including alcohol, without delaying operational decisions.
However, changing the testing method does not by itself answer the policy question. A positive THC result on an oral fluid test, a urine test, or a laboratory confirmation still has to be interpreted against the employer’s written standards and the responsibilities of the role. Best practices for Texas employers continue to emphasize the importance of a written drug and alcohol policy, documented employee acknowledgment, and clear notice of the consequences associated with violations or positive results. If an employer plans to reject candidates who test positive for THC, that rule should be stated plainly in pre-employment materials and applied in the same way from one candidate to the next.
Consistency is becoming even more critical because candidates increasingly raise questions tied to rescheduling, medical use, and hemp-derived products. Employers often cannot tell from a standard THC result whether the source was marijuana, THCA, Delta-8, or another cannabinoid product, and from a workplace risk perspective, that distinction may not change the basic fact that THC is present. When employers deviate from their own policies on a case-by-case basis, they create avoidable risk and confusion. A consistent, transparent approach—supported by clear documentation—remains the most defensible way to handle THC in hiring decisions.
For a medical or professional readership, the deeper point is that marijuana rescheduling has not eliminated workplace screening authority; it has heightened the need for thoughtful program design. Employers now need drug testing programs that are medically credible, operationally efficient, and legally coherent. That includes choosing the right specimen type, defining which drug panels are appropriate for which jobs, documenting how decisions are made, and distinguishing between pre-employment screening and impairment-related investigations. In many settings, oral fluid programs built around saliva drug test kits or a saliva drug test kit 10 panel support these goals by shortening turnaround times and focusing attention on more recent drug exposure.
The practical answer to the core question is straightforward. Employers can still reject candidates for THC after marijuana rescheduling, particularly when they have a written policy, the role is safety-sensitive, or there are legitimate business reasons for maintaining a THC-free hiring standard. What has changed is not the basic right to test, but the need for sharper judgment in how tests are selected, how results are interpreted, and how those results are communicated to applicants. As cannabis law continues to evolve, the employers best positioned to adapt will be those that pair clear policy language with modern testing methods, including oral fluid options such as an oral swab drug screen test, an instant saliva drug screen, or a saliva drug screen kit with alcohol, where those tools are an appropriate fit for the workplace program.
DrugScreens.com is a nationwide supplier of drug screening supplies, including CLIA-waived urine cups, dip cards and saliva kits in employment and forensic use applications.Â
